PL2614832T3 - Diagnostyka i leczenie stanu przedrzucawkowego - Google Patents
Diagnostyka i leczenie stanu przedrzucawkowegoInfo
- Publication number
- PL2614832T3 PL2614832T3 PL13160275T PL13160275T PL2614832T3 PL 2614832 T3 PL2614832 T3 PL 2614832T3 PL 13160275 T PL13160275 T PL 13160275T PL 13160275 T PL13160275 T PL 13160275T PL 2614832 T3 PL2614832 T3 PL 2614832T3
- Authority
- PL
- Poland
- Prior art keywords
- preeclampsia
- diagnosis
- treatment
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/41—Porphyrin- or corrin-ring-containing peptides
- A61K38/42—Haemoglobins; Myoglobins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/99—Miscellaneous (1.14.99)
- C12Y114/99003—Heme oxygenase (1.14.99.3)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
- G01N33/721—Haemoglobin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0700339 | 2007-02-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2614832T3 true PL2614832T3 (pl) | 2017-01-31 |
Family
ID=39295873
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL13160275T PL2614832T3 (pl) | 2007-02-12 | 2008-02-12 | Diagnostyka i leczenie stanu przedrzucawkowego |
PL08707674T PL2111555T3 (pl) | 2007-02-12 | 2008-02-12 | Diagnostyka stanu przedrzucawkowego |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL08707674T PL2111555T3 (pl) | 2007-02-12 | 2008-02-12 | Diagnostyka stanu przedrzucawkowego |
Country Status (18)
Country | Link |
---|---|
US (3) | US8568999B2 (pl) |
EP (3) | EP2111555B1 (pl) |
JP (2) | JP5604111B2 (pl) |
KR (2) | KR101608501B1 (pl) |
AU (1) | AU2008214837B2 (pl) |
BR (1) | BRPI0808340A2 (pl) |
CA (1) | CA2674204C (pl) |
DK (2) | DK2614832T3 (pl) |
EA (2) | EA022609B1 (pl) |
ES (2) | ES2426069T3 (pl) |
HR (2) | HRP20130809T1 (pl) |
HU (1) | HUE031613T2 (pl) |
MX (2) | MX347788B (pl) |
NZ (1) | NZ578077A (pl) |
PL (2) | PL2614832T3 (pl) |
PT (2) | PT2614832T (pl) |
WO (1) | WO2008098734A1 (pl) |
ZA (1) | ZA200905101B (pl) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA022609B1 (ru) * | 2007-02-12 | 2016-02-29 | А1М Фарма Аб | Применение свободного фетального гемоглобина в качестве маркера преэклампсии |
EP2313106B1 (en) | 2008-07-18 | 2016-03-30 | A1M Pharma AB | Medical use of the radical scavenger and antioxidant alpha-1-microglobulin |
WO2011095981A1 (en) * | 2010-02-03 | 2011-08-11 | St. John's Research Institute | An in-vitro method for characterizing hemoglobin variant |
CN102906568B (zh) * | 2010-03-24 | 2014-11-12 | 普利鲁米那诊断公司 | 作为先兆子痫早期阶段标志物的HbF和A1M |
WO2011125877A1 (ja) * | 2010-03-31 | 2011-10-13 | 積水メディカル株式会社 | イムノクロマトグラフィーを利用した測定方法、イムノクロマトグラフィー用テストストリップ及びイムノクロマトグラフィー用測定試薬キット |
WO2013053359A1 (en) | 2011-10-14 | 2013-04-18 | Aarhus Universitet | Diagnostic and prognostic use of prombp-complexes |
HUE030559T2 (en) * | 2012-09-05 | 2017-05-29 | A1M Pharma Ab | Alpha-1 microglobulin for use in the treatment of mitochondrial diseases |
US10928402B2 (en) | 2012-12-28 | 2021-02-23 | Nx Prenatal Inc. | Treatment of spontaneous preterm birth |
US20140186332A1 (en) * | 2012-12-28 | 2014-07-03 | NX Pharmagen | Biomarkers of preterm birth |
CA2977458A1 (en) | 2015-03-16 | 2016-09-22 | A1M Pharma Ab | Biomarkers for preeclampsia |
KR101732933B1 (ko) | 2015-07-29 | 2017-05-08 | 영남대학교 산학협력단 | 신생아의 성장 또는 심혈관계 질환 예후 진단 방법 |
JP2019505815A (ja) | 2015-12-04 | 2019-02-28 | エヌエックス・プリネイタル・インコーポレイテッドNX Prenatal Inc. | 自然早産リスクを層別化するための循環マイクロ粒子の使用 |
EP4317959A3 (en) * | 2018-03-19 | 2024-03-27 | Regeneron Pharmaceuticals, Inc. | Microchip capillary electrophoresis assays and reagents |
CN111626280B (zh) * | 2020-04-13 | 2021-09-07 | 北京邮电大学 | 一种无定位点答题卡识别方法和装置 |
WO2024053586A1 (ja) * | 2022-09-05 | 2024-03-14 | 栄研化学株式会社 | 遊離ヘモグロビン測定試薬、遊離ヘモグロビン測定方法および抗ヘモグロビン抗体 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1337778A1 (ru) | 1984-06-25 | 1987-09-15 | Новосибирский государственный медицинский институт | Способ диагностики т жести позднего токсикоза беременных |
US5079171A (en) | 1988-09-15 | 1992-01-07 | Adeza Biomedical Corporation | Determining pregnancy induced hypertension and eclampsia by immunoassay of cellular fibronectin |
US5238819A (en) | 1988-12-14 | 1993-08-24 | The Regents Of The University Of California | Diagnostic assay for the detection of preeclampsia |
US5939272A (en) | 1989-01-10 | 1999-08-17 | Biosite Diagnostics Incorporated | Non-competitive threshold ligand-receptor assays |
US5108898A (en) | 1989-01-18 | 1992-04-28 | Peters John H | Use of fibronectin having a variable included type III repeat sequence as a marker for toxemia in pregnancy |
US5612034A (en) * | 1990-10-03 | 1997-03-18 | Redcell, Inc. | Super-globuling for in vivo extended lifetimes |
US5166133A (en) | 1991-04-17 | 1992-11-24 | Cetus Corporation | Method for inhibing adhesion of white blood cells to endothelial cells |
US6103691A (en) | 1994-03-23 | 2000-08-15 | Tschesche; Harald | Utilisation of angiogenin and/or α1 -microglobulin and/or complement factor D in order to inhibit the secretion of proteins |
US5849474A (en) * | 1995-12-06 | 1998-12-15 | Olson; Camilla M. | Diagnosis of preeclampsia in mammals |
US5910482A (en) * | 1996-03-19 | 1999-06-08 | Board Of Regents, The University Of Texas System | Treatment or prevention of preeclampsia, eclampsia with calcitonin gene related peptide, CGRP analog, progestational agent, nitric oxide source, and cyclooxygenase inhibitor |
US6169816B1 (en) * | 1997-05-14 | 2001-01-02 | Applied Imaging, Inc. | Identification of objects of interest using multiple illumination schemes and finding overlap of features in corresponding multiple images |
JP2001348342A (ja) | 2001-04-12 | 2001-12-18 | Nippon Zoki Pharmaceut Co Ltd | 免疫調整・抗炎症剤 |
CA2414073A1 (en) | 2001-05-04 | 2002-11-14 | Gunars E. Valkirs | Diagnostic markers of acute coronary syndromes and methods of use thereof |
DE60219642T2 (de) | 2001-09-04 | 2008-01-17 | Iq Corp. B.V. | Bestimung und quantifizierung von erythrocytenpopulation in proben |
EP1491891A4 (en) * | 2002-03-29 | 2005-11-09 | Matsushita Electric Ind Co Ltd | METHOD AND DEVICE FOR TREATING BLOOD, METHOD AND DEVICE FOR MEASURING HEMOGLOBINS |
DE10237423A1 (de) | 2002-08-16 | 2004-02-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von LCK-Inhibitoren für die Behandlung von immunologischen Erkrankungen |
WO2005002515A2 (en) * | 2003-06-20 | 2005-01-13 | Biomarin Pharmaceutical Inc. | Delivery of therapeutic compounds to the brain and other tissues |
AR045074A1 (es) | 2003-07-23 | 2005-10-12 | Applied Research Systems | Uso de cd164 soluble en desordenes inflamatorios y autoinmunes |
CN1882331A (zh) * | 2003-11-26 | 2006-12-20 | 塞诺菲-安万特德国有限公司 | 作为心血管风险升高指示剂的肾小管性蛋白尿 |
WO2005093413A2 (en) | 2004-03-22 | 2005-10-06 | Yale University | Diagnosis and treatment of preeclampsia |
US20070292421A1 (en) * | 2005-07-28 | 2007-12-20 | Feinberg Bruce B | Method for treating preeclampsia |
GB0600916D0 (en) | 2006-01-17 | 2006-02-22 | Perkinelmer Instr Las Inc | detecting and predicting pre-eclampsia |
AU2007207089A1 (en) | 2006-01-18 | 2007-07-26 | Wick, Immunologische Diagnostik U. Beratung Kg | Test systems for the analysis of polypeptides and cells adhering to silicones |
EA022609B1 (ru) * | 2007-02-12 | 2016-02-29 | А1М Фарма Аб | Применение свободного фетального гемоглобина в качестве маркера преэклампсии |
WO2009108073A1 (en) | 2008-02-28 | 2009-09-03 | Auckland Uniservices Limited | Biomarkers for prediction of preeclampsia and/or cardiovascular disease |
EP2313106B1 (en) | 2008-07-18 | 2016-03-30 | A1M Pharma AB | Medical use of the radical scavenger and antioxidant alpha-1-microglobulin |
CN102906568B (zh) | 2010-03-24 | 2014-11-12 | 普利鲁米那诊断公司 | 作为先兆子痫早期阶段标志物的HbF和A1M |
-
2008
- 2008-02-12 EA EA200970758A patent/EA022609B1/ru not_active IP Right Cessation
- 2008-02-12 ES ES08707674T patent/ES2426069T3/es active Active
- 2008-02-12 PT PT131602757T patent/PT2614832T/pt unknown
- 2008-02-12 NZ NZ578077A patent/NZ578077A/en not_active IP Right Cessation
- 2008-02-12 KR KR1020147017284A patent/KR101608501B1/ko active IP Right Grant
- 2008-02-12 US US12/526,941 patent/US8568999B2/en not_active Expired - Fee Related
- 2008-02-12 HU HUE13160275A patent/HUE031613T2/en unknown
- 2008-02-12 DK DK13160275.7T patent/DK2614832T3/da active
- 2008-02-12 AU AU2008214837A patent/AU2008214837B2/en not_active Ceased
- 2008-02-12 MX MX2013001577A patent/MX347788B/es unknown
- 2008-02-12 MX MX2009008408A patent/MX2009008408A/es active IP Right Grant
- 2008-02-12 BR BRPI0808340A patent/BRPI0808340A2/pt not_active Application Discontinuation
- 2008-02-12 EA EA201500335A patent/EA031877B1/ru not_active IP Right Cessation
- 2008-02-12 CA CA2674204A patent/CA2674204C/en not_active Expired - Fee Related
- 2008-02-12 KR KR1020097019056A patent/KR101454013B1/ko active IP Right Grant
- 2008-02-12 WO PCT/EP2008/001051 patent/WO2008098734A1/en active Application Filing
- 2008-02-12 PL PL13160275T patent/PL2614832T3/pl unknown
- 2008-02-12 PT PT87076741T patent/PT2111555E/pt unknown
- 2008-02-12 EP EP08707674.1A patent/EP2111555B1/en not_active Not-in-force
- 2008-02-12 DK DK08707674.1T patent/DK2111555T3/da active
- 2008-02-12 EP EP13160278.1A patent/EP2613150A1/en not_active Withdrawn
- 2008-02-12 PL PL08707674T patent/PL2111555T3/pl unknown
- 2008-02-12 JP JP2009548631A patent/JP5604111B2/ja not_active Expired - Fee Related
- 2008-02-12 EP EP13160275.7A patent/EP2614832B1/en not_active Not-in-force
- 2008-02-12 ES ES13160275.7T patent/ES2599003T3/es active Active
-
2009
- 2009-07-21 ZA ZA2009/05101A patent/ZA200905101B/en unknown
-
2013
- 2013-07-19 JP JP2013150603A patent/JP5792772B2/ja not_active Expired - Fee Related
- 2013-08-28 HR HRP20130809AT patent/HRP20130809T1/hr unknown
- 2013-09-17 US US14/028,971 patent/US20140065170A1/en not_active Abandoned
-
2016
- 2016-10-03 HR HRP20161266TT patent/HRP20161266T1/hr unknown
-
2018
- 2018-01-26 US US15/880,943 patent/US10359406B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT2614832T (pt) | Diagnóstico de pré-eclâmpsia | |
IL207360A0 (en) | Methods of diagnosing and treating parp - mediated diseases | |
GB0610867D0 (en) | Treatment of pain | |
EP2170198A4 (en) | MEDICAL SYSTEM AND METHOD OF USE | |
GB0911580D0 (en) | Use of one or more cannabinoids in the treatment of epilepsy | |
IL193748A0 (en) | Treatment of pain | |
GB0608647D0 (en) | Methods of diagnosis and treatment | |
GB0922085D0 (en) | Cancer diagnosis and treatment | |
ZA200806808B (en) | Treatment of stressed patients | |
GB201108964D0 (en) | Medicament and method of diagnosis | |
GB0918392D0 (en) | Diagnostic and therapeutic methods | |
IL213703A (en) | Compounds for the treatment of pain and other diseases | |
EP2470268A4 (en) | PURING-ORIENTED DIAGNOSIS AND THERAPY OF WOUNDS | |
GB2465907B (en) | VHZ for diagnosis and treatment of cancer | |
GB0708452D0 (en) | Treatment of nuclear studge | |
GB0610868D0 (en) | Treatment of pain | |
EP2361317A4 (en) | USE OF EIF3M FOR THE DIAGNOSIS AND TREATMENT OF CANCER | |
GB0901837D0 (en) | Cancer diagnosis and treatment | |
GB0709092D0 (en) | Diagnosis and method of disease | |
HRP20151393T8 (hr) | UPORABA BENZIDAMINA U LIJEČENJU BOLESTI KOJE SU p40-OVISNE | |
EP2164494A4 (en) | Methods of Treatment | |
GB0723100D0 (en) | Treatment of HFnEF | |
HU0900195D0 (en) | Diagnosis and treatment of gluten-induced autoimmune diseases | |
GB0616450D0 (en) | Treatment of pain | |
GB0600244D0 (en) | Treatment and diagnosis of pathogens |